Alternatives to Syneos Health
Syneos Health is a Biotechnology tool: A fully integrated biopharmaceutical solutions organization providing clinical development and commercialization services to life sciences companies. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Syneos Health
Precision Medicine GroupNot ratedSpecialized services for pharmaceutical and life sciences clients across product development and commercialization.
IQVIANot ratedLeveraging AI and advanced analytics to drive innovation in healthcare and life sciences.
Moderna2.0 out of 5 (1)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- JUJuno TherapeuticsNot rated
Biotechnology company focused on developing cancer immunotherapies.
Kite PharmaNot ratedBiotechnology company developing and commercializing cell therapies for cancer treatment.
CRISPR TherapeuticsNot ratedBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Seaport TherapeuticsNot ratedDeveloping novel therapeutics to restore gut lymphatic function.
- CRCreate MedicinesNot rated
Developing in vivo immunotherapies for autoimmune diseases and cancer.
EnteromeNot ratedClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
Supernus PharmaceuticalsNot ratedBiopharmaceutical company developing and commercializing CNS disease treatments.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
MironidNot ratedBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
CelerionNot ratedA global leader in clinical pharmacology and bioanalytical sciences.
Spark TherapeuticsNot ratedA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
KaliVir Immunotherapeutics, Inc.5.0 out of 5 (1)Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
Janux TherapeuticsNot ratedA clinical-stage biopharmaceutical company developing novel immunotherapies.
Precision BioSciencesNot ratedA clinical-stage biotechnology company developing in vivo gene editing therapies.
Showing the next 20 closest matches. See the rest on the Syneos Health profile.
Sponsored rows are paid and labelled. Advertise on this page

